News and Press Releases

Prosarix associated with Bloomsbury Antibiotic Development Company - runner up in RCUK 2007/08 Business Plan Competition

Cambridge, UK, October 21st 2008 — Prosarix is part of a consortium, the Bloomsbury Antibiotic Development Company (BADCo), set up by Dr Sandy Primrose to exploit the urgent clinical need for new classes of antibiotic active against new molecular targets. The leading scientists behind BADCo include Prof Neil Stoker (Royal Veterinary College), Prof Gabriel Waksman (Birkbeck College) and Prof Simon Gibbons (School of Pharmacy) who have identified a number of novel targets for TB and other bacterial diseases.

The BADCo Business Plan was submitted to the Research Councils UK Business Plan Competition and presented by Prof Stoker. The competition is open to researchers based in UK Higher Education Institutions (HEI's) or Public Sector Research Establishments (PSRE) that are eligible to hold Research Council grants from across the whole spectrum of academic research within the remit of the seven Research Councils.

On Monday 20 October 2008 it was announced that The Bloomsbury Antibiotic Discovery Company was a runner up in the competition.


Prof Neil Stoker (RVC, centre) holding a runner up award with Patricia Latter (Head of Business Development, RVC, right) and Bill Hamilton (CEO Prosarix, left).


©Prosarix 2007-2020

℅ RxCelerate Ltd, Moneta B280, Babraham Research Park, Cambridge, CB22 3AT ¦ +44 (0)1223 839557 ¦ ¦ legal